BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6954290)

  • 1. [Basic study on efficacy of cefmetazole against osseous and articular infections (author's transl)].
    Kawashima M; Tamura H; Kitahara Y; Jinyama K
    Jpn J Antibiot; 1982 Mar; 35(3):835-9. PubMed ID: 6954290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Annual changes of sensitivities of Staphylococcus aureus to several antibiotics].
    Kosakai N; Mori M; Shitara M; Kudo M; Morimoto M
    Jpn J Antibiot; 1982 Aug; 35(8):1934-44. PubMed ID: 6961238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical evaluations of cefmetazole against dermal infections by S. aureus (author's transl)].
    Watanabe Y; Yokoyama M; Itoh K; Yamada K
    Jpn J Antibiot; 1982 Jan; 35(1):261-7. PubMed ID: 6951062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole].
    Toyonaga Y; Kurosu Y; Sugita M; Kumagai K; Hori M; Hoshina S; Kurosaka K; Nishiyama H; Shinohara N; Takahashi T; Deguchi K 210 P
    Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on cefmetazole in the neonatal period (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K
    Jpn J Antibiot; 1981 Jun; 34(6):881-92. PubMed ID: 6945448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of clinical application of cefmetazole in perinatal period (author's transl)].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1981 Jun; 34(6):915-24. PubMed ID: 6945452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
    Yokota T; Yoshida R; Utsui Y; Tajima M
    Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
    Deguchi K; Kawamura S; Sugita R; Fujimaki Y; Ohsawa H
    Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nationwide study of the antimicrobial susceptibility of clinical isolates of Proteus group in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1987 Apr; 40(4):823-42. PubMed ID: 3475483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of effectiveness of cefmetazole in bone and joint infections in the orthopedic field].
    Yamane S; Tako H; Yoda Y
    Jpn J Antibiot; 1982 Aug; 35(8):1945-50. PubMed ID: 6759694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental studies of cefmetazole in the field of dermatology].
    Suwaki M; Kashiwa N; Nohara N
    Jpn J Antibiot; 1982 Aug; 35(8):1957-60. PubMed ID: 6961240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical studies of cefmetazole in the field of oral surgery].
    Minami Y; Taguchi M; Nanba R; Tsuto H; Yamamoto T; Ueda K; Tsushima T; Morihana T; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1982 May; 35(5):1308-21. PubMed ID: 6957626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of air tourniquet on the antibiotics concentration, in bone marrow, injected just before the start of operation.
    Tomita M; Motokawa S
    Mod Rheumatol; 2007; 17(5):409-12. PubMed ID: 17929134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory and clinical studies on 6059-S in children (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 May; 34(5):782-99. PubMed ID: 6457176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trials of cefmetazole for pneumonia and pyothorax caused by Staphylococcus aureus resistant to cefazolin].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
    Jpn J Antibiot; 1984 Jan; 37(1):88-96. PubMed ID: 6587132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.